Literature DB >> 11411955

Chemoprophylactic praziquantel treatment in experimental hydatidosis.

M A Urrea-París1, N Casado, M J Moreno, F Rodriguez-Caabeiro.   

Abstract

In the present study, new data on the chemoprophylactic treatment of experimental hydatid disease with praziquantel are presented. In vivo studies have been performed reducing the treatment to 1 and 2 months. NMRI female mice inoculated with protoscolices of Echinococcus granulosus were treated with praziquantel 48 h p.i. at a dose of 600 mg/kg, 5 days a week for 1 or 2 months. After 4 months p.i. the animals were killed, and the cysts obtained were counted, weighed and processed for observations by means of transmission electron microscopy. Both wet weight and number of hyaline cysts found in treated mice were significantly lower than those found in control groups in both experiments (1 and 2 months of treatment), obtaining a high efficacy in all cases. Moreover, severe ultrastructural damage in the treated cysts was seen compared to the control cysts. The reduction in treatment time lays the basis for an important advance in the control and prevention of hydatidosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411955     DOI: 10.1007/s004360100390

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  8 in total

1.  Anaphylactic shock ensuing therapeutic puncture of an echinococcal cyst.

Authors:  Joachim Richter; Efim Profis; Martha C Holtfreter; Arzu Orhun; Irmela Müller-Stöver; Hülya Dedelen; Ralf Kubitz
Journal:  Parasitol Res       Date:  2014-12-31       Impact factor: 2.289

2.  The destructive effects of high-intensity focused ultrasound on hydatid cysts enhanced by ultrasound contrast agent and superabsorbent polymer alone or in combination.

Authors:  Hui Cai; Lu-Lu Chen; Bin Ye; Ai-Bo Liu; Jing Zhang; Yi-Feng Zhao
Journal:  Parasitol Res       Date:  2012-11-18       Impact factor: 2.289

3.  In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus.

Authors:  Arunasalam Naguleswaran; Martin Spicher; Nathalie Vonlaufen; Luis M Ortega-Mora; Paul Torgerson; Bruno Gottstein; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

4.  Effect of octenidine dihydrochloride on viability of protoscoleces in hepatic and pulmonary hydatid diseases.

Authors:  Ihsan Hakki Ciftci; Hidir Esme; Dursun Ali Sahin; Okan Solak; Murat Sezer; Osman Nuri Dilek
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

5.  In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.

Authors:  Negin Torabi; Faramarz Dobakhti; Soghrat Faghihzadeh; Ali Haniloo
Journal:  Parasitol Res       Date:  2018-04-03       Impact factor: 2.289

6.  Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm.

Authors:  Shuyu Xie; Baoliang Pan; Baoxin Shi; Zhuangzhi Zhang; Xu Zhang; Ming Wang; Wenzhong Zhou
Journal:  Int J Nanomedicine       Date:  2011-10-18

Review 7.  Treatment of echinococcosis: albendazole and mebendazole--what else?

Authors:  Andrew Hemphill; Britta Stadelmann; Reto Rufener; Markus Spiliotis; Ghalia Boubaker; Joachim Müller; Norbert Müller; Daniela Gorgas; Bruno Gottstein
Journal:  Parasite       Date:  2014-12-22       Impact factor: 3.000

8.  Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control.

Authors:  Bin Jiang; Xiao-Nong Zhou; Hao-Bing Zhang; Yi Tao; Le-Le Huo; Ni Liu
Journal:  Infect Dis Poverty       Date:  2017-09-15       Impact factor: 4.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.